Dulaglutide vs UBT251

Head-to-head comparison of Dulaglutide (Recombinant GLP-1 receptor agonist Fc fusion protein) and UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyDulaglutideUBT251
CategoryWeight ManagementWeight Management
Full NameRecombinant GLP-1 receptor agonist Fc fusion proteinUBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist
Molecular Weight~63,000 DaN/A
Half-LifeAbout 5 daysApproximately 1 week
Amino AcidsN/AN/A
Typical Dose0.75-4.5 mg weeklyInvestigational; no established human dose
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count7008
Research StatusApprovedPre-clinical

Dulaglutide Benefits

  • modest weight loss
  • lower A1c
  • weekly dosing convenience
  • cardiometabolic benefit

UBT251 Benefits

  • weight reduction
  • improved satiety
  • enhanced energy expenditure
  • better insulin sensitivity

Dulaglutide Dosing

0.75-4.5 mg SC weekly|Increase based on response and tolerance|Administer on the same day each week

UBT251 Dosing

once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment

Dulaglutide Side Effects

  • nausea
  • diarrhea
  • injection-site reactions

UBT251 Side Effects

  • nausea
  • diarrhea
  • fatigue

Research Overview

Dulaglutide

Dulaglutide has repeatedly shown small-to-moderate reductions in body weight alongside glycemic improvement in large diabetes trials. It is a useful comparator for GLP-1 receptor agonist effects on appetite and weight.

UBT251

Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Dulaglutide stacks with:

metformindiet-and-exercise

UBT251 stacks with:

metforminorlistat
GLP-1RAweekly-injectiontype-2-diabetesmodest-weight-lossglp1gipglucagontriagonistweight-management